These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8114855)
1. Efficacy of intravitreal foscarnet in a patient with AIDS. Lieberman RM; Orellana J; Melton RC N Engl J Med; 1994 Mar; 330(12):868-9. PubMed ID: 8114855 [No Abstract] [Full Text] [Related]
2. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome. Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542 [No Abstract] [Full Text] [Related]
8. Foscarnet or ganciclovir for treatment of AIDS and CMV retinitis. Moyle G; Gazzard BG Am J Med; 1995 Mar; 98(3):319-20. PubMed ID: 7872356 [No Abstract] [Full Text] [Related]
9. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed. AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828 [No Abstract] [Full Text] [Related]
10. Resolution of oral hairy leukoplakia during treatment with foscarnet. Albrecht H; Stellbrink HJ; Brewster D; Greten H AIDS; 1994 Jul; 8(7):1014-6. PubMed ID: 7946089 [No Abstract] [Full Text] [Related]
11. New treatment options for CMV retinitis in AIDS. Lalezari JP Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896 [No Abstract] [Full Text] [Related]
12. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir. Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441 [No Abstract] [Full Text] [Related]
13. Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease. Balfour HH Postgrad Med; 1995 Jan; 97(1):109-13, 117-8. PubMed ID: 7816708 [TBL] [Abstract][Full Text] [Related]
14. Care of the patient with AIDS and cytomegalovirus retinitis (continuing education credit). Frederick MC J Ophthalmic Nurs Technol; 1994; 13(4):156-60; quiz 180-1. PubMed ID: 8064878 [No Abstract] [Full Text] [Related]
15. FDA notifications. FDA approves generic foscarnet sodium injection. AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16110563 [No Abstract] [Full Text] [Related]
16. High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS. Diaz-Llopis M; España E; Muñoz G; Navea A; Chipont E; Cano J; Menezo JL; Romero FJ Br J Ophthalmol; 1994 Feb; 78(2):120-4. PubMed ID: 8123619 [TBL] [Abstract][Full Text] [Related]
17. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522 [TBL] [Abstract][Full Text] [Related]
18. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir. Jabs DA Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191 [TBL] [Abstract][Full Text] [Related]
19. [Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week]. Mallolas J; Gatell JM; Gómez-Sirvent JL; Buira E; Zamora L; Alecrim-Andrade J; Adán A; Morales M; Miró JM; Lonća M; Guelar A; Soriano E Enferm Infecc Microbiol Clin; 1997 Feb; 15(2):61-4. PubMed ID: 9101748 [TBL] [Abstract][Full Text] [Related]
20. Care of the patient with AIDS and cytomegalovirus retinitis. Frederick MC Todays OR Nurse; 1994; 16(5):36-40. PubMed ID: 7974648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]